Application-Based Inspection
These inspections are conducted for about 20% of application reviews by the FDA. They are part of the application review process for marketing new drugs, devices, or biologics. The inspections assess whether the product is manufactured in compliance with FDA regulations, ensure the facility can consistently produce the product, and verify the accuracy and completeness of the submitted data.